12:00 AM
Sep 07, 1999
 |  BC Week In Review  |  Company News  |  Deals

OSI, Tanabe Seiyaku deal

The companies will discover and develop small molecule compounds to treat Type II diabetes based on discoveries from OSIP's collaboration with the Vanderbilt...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >